Minerals
Evidence: moderate_human
Chromium potentiates insulin signaling by enhancing insulin receptor tyrosine kinase activity, likely through the chromodulin (low-molecular-weight chromium-binding substance) pathway. Chromodulin amplifies insulin receptor autophosphorylation by 8-fold, enhancing downstream IRS-1/PI3K/Akt signaling and GLUT4 translocation. Chromium also activates AMPK, increases insulin receptor number on cell surfaces, and may reduce hepatic glucose output. Picolinate chelation enhances absorption from <3% (chromium chloride) to ~10%.
Standard: 200-500 mcg chromium picolinate daily
Loading: 1000 mcg/day for insulin resistance (split doses, 12 weeks, under supervision)
Maintenance: 200 mcg/day
Administration: oral
Timing: With meals, particularly carbohydrate-containing meals. Split dosing for higher amounts.
Duration: ongoing or cycle 12 weeks on, 4 weeks off
Primarily valuable for clients with insulin resistance, metabolic syndrome, type 2 diabetes, or carbohydrate cravings. Benefits are most pronounced in chromium-deficient individuals — those with adequate status show less response. The picolinate safety debate at high doses (>1000 mcg) has led some practitioners to prefer polynicotinate form. Chromium depletion is accelerated by high sugar intake and strenuous exercise. Can be a useful component of a carb-craving/blood-sugar-stabilization stack alongside berberine and ALA.
Chromium picolinate is the most studied form. Chromium polynicotinate (niacin-bound, Chromate brand) and chromium histidinate are alternatives with potentially fewer safety concerns than picolinate at high doses. Trivalent chromium (Cr3+) is the safe supplemental form — hexavalent chromium (Cr6+) is the toxic industrial chemical. Brands: Thorne Chromium Picolinate, NOW Chromium Picolinate.
Take the free assessment and get personalized recommendations based on your biology and goals.
Get Your Free Protocolor take the assessment →